Literature DB >> 11685296

Hormones in the critically ill patient: to intervene or not to intervene?

J J Ligtenberg1, A R Girbes, J A Beentjes, J E Tulleken, T S van der Werf, J G Zijlstra.   

Abstract

Critically ill patients show a variety of hormonal changes that appear to differ considerably in acute and prolonged critical illness. Whether these endocrine alterations serve as physiological adaptation or contribute to further deterioration remains an intriguing question. We review the recent literature and discuss whether measuring circulating hormone concentrations, performing stimulation tests, and intervening with hormone substitution could contribute to the recovery of critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11685296     DOI: 10.1007/s001340101050

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  4 in total

1.  Targeted thyroid testing in acute illness: achieving success through audit.

Authors:  M A Adlan; V Neel; S S Lakra; L N R Bondugulapati; L D K E Premawardhana
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

2.  Early enteral nutrition positively influences endocrine function in traumatic brain injury patients.

Authors:  M Chourdakis; M Kraus; T Tzellos; D Kouvelas
Journal:  Hippokratia       Date:  2011-07       Impact factor: 0.471

3.  Impact of fluconazole prophylaxis on cortisol levels in critically ill surgical patients.

Authors:  Shelley S Magill; Thanyawee Puthanakit; Sandra M Swoboda; Kathryn A Carson; Roberto Salvatori; Pamela A Lipsett; Craig W Hendrix
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

4.  Post-translational modifications of transthyretin affect the triiodonine-binding potential.

Authors:  Andrea Henze; Thomas Homann; Mustafa Serteser; Ozge Can; Ozlem Sezgin; Abdurrahman Coskun; Ibrahim Unsal; Florian J Schweigert; Aysel Ozpinar
Journal:  J Cell Mol Med       Date:  2014-10-14       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.